<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-archivearticle1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Adv</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Adv</journal-id>
    <journal-id journal-id-type="publisher-id">sciadv</journal-id>
    <journal-id journal-id-type="hwp">advances</journal-id>
    <journal-title-group>
      <journal-title>Science Advances</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2375-2548</issn>
    <publisher>
      <publisher-name>American Association for the Advancement of Science</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8514091</article-id>
    <article-id pub-id-type="pmid">34644115</article-id>
    <article-id pub-id-type="publisher-id">abg6045</article-id>
    <article-id pub-id-type="doi">10.1126/sciadv.abg6045</article-id>
    <article-categories>
      <subj-group subj-group-type="article-type">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Biomedicine and Life Sciences</subject>
      </subj-group>
      <subj-group subj-group-type="legacy-article-type">
        <subject>SciAdv r-articles</subject>
      </subj-group>
      <subj-group subj-group-type="field">
        <subject>Cancer</subject>
        <subject>Research Methods</subject>
      </subj-group>
      <subj-group subj-group-type="overline">
        <subject>Cancer</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3145-4032</contrib-id>
        <name>
          <surname>Nikolic</surname>
          <given-names>Ana</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-data-curation/">Data curation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-investigation/">Investigation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Visualization" vocab-term-identifier="https://web.archive.org/web/20180313224017/http://dictionary.casrai.org/Contributor_Roles/Visualization">Visualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff3" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9796-5065</contrib-id>
        <name>
          <surname>Singhal</surname>
          <given-names>Divya</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-data-curation/">Data curation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-investigation/">Investigation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff3" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ellestad</surname>
          <given-names>Katrina</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-investigation/">Investigation</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff3" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6769-6311</contrib-id>
        <name>
          <surname>Johnston</surname>
          <given-names>Michael</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff3" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Shen</surname>
          <given-names>Yaoqing</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-investigation/">Investigation</role>
        <xref rid="aff4" ref-type="aff">
          <sup>4</sup>
        </xref>
        <xref rid="aff5" ref-type="aff">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gillmor</surname>
          <given-names>Aaron</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff3" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Morrissy</surname>
          <given-names>Sorana</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-investigation/">Investigation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <xref rid="award822840" ref-type="award"/>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff3" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cairncross</surname>
          <given-names>J. Gregory</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-funding-acquisition/">Funding acquisition</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-supervision/">Supervision</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff6" ref-type="aff">
          <sup>6</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3394-2208</contrib-id>
        <name>
          <surname>Jones</surname>
          <given-names>Steven</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-project-administration/">Project administration</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <xref rid="aff4" ref-type="aff">
          <sup>4</sup>
        </xref>
        <xref rid="aff5" ref-type="aff">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0929-9478</contrib-id>
        <name>
          <surname>Lupien</surname>
          <given-names>Mathieu</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff7" ref-type="aff">
          <sup>7</sup>
        </xref>
        <xref rid="aff8" ref-type="aff">
          <sup>8</sup>
        </xref>
        <xref rid="aff9" ref-type="aff">
          <sup>9</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9798-1551</contrib-id>
        <name>
          <surname>Chan</surname>
          <given-names>Jennifer A.</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-funding-acquisition/">Funding acquisition</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff6" ref-type="aff">
          <sup>6</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Neri</surname>
          <given-names>Paola</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-supervision/">Supervision</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Visualization" vocab-term-identifier="https://web.archive.org/web/20180313224017/http://dictionary.casrai.org/Contributor_Roles/Visualization">Visualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff6" ref-type="aff">
          <sup>6</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bahlis</surname>
          <given-names>Nizar</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-data-curation/">Data curation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-investigation/">Investigation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff6" ref-type="aff">
          <sup>6</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8451-8207</contrib-id>
        <name>
          <surname>Gallo</surname>
          <given-names>Marco</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-funding-acquisition/">Funding acquisition</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-project-administration/">Project administration</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-supervision/">Supervision</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Visualization" vocab-term-identifier="https://web.archive.org/web/20180313224017/http://dictionary.casrai.org/Contributor_Roles/Visualization">Visualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="award741806" ref-type="award"/>
        <xref rid="award822838" ref-type="award"/>
        <xref rid="award822839" ref-type="award"/>
        <xref rid="award741805" ref-type="award"/>
        <xref rid="award741807" ref-type="award"/>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff3" ref-type="aff">
          <sup>3</sup>
        </xref>
        <xref rid="cor1" ref-type="corresp">*</xref>
      </contrib>
      <aff id="aff1"><label>1</label>Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</aff>
      <aff id="aff2"><label>2</label>Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</aff>
      <aff id="aff3"><label>3</label>Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</aff>
      <aff id="aff4"><label>4</label>Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.</aff>
      <aff id="aff5"><label>5</label>Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.</aff>
      <aff id="aff6"><label>6</label>Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</aff>
      <aff id="aff7"><label>7</label>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.</aff>
      <aff id="aff8"><label>8</label>Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.</aff>
      <aff id="aff9"><label>9</label>Ontario Institute for Cancer Research, Toronto, ON, Canada.</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Corresponding author. Email: <email xlink:href="marco.gallo@ucalgary.ca">marco.gallo@ucalgary.ca</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>10</month>
      <year>2021</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pub">
      <day>13</day>
      <month>10</month>
      <year>2021</year>
    </pub-date>
    <volume>7</volume>
    <issue>42</issue>
    <elocation-id>eabg6045</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>1</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>17</day>
        <month>8</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense" start_date="2021-10-13">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution license</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="sciadv.abg6045.pdf"/>
    <abstract abstract-type="teaser">
      <p>Inferring structural variants in cancer single-cell chromatin accessibility data links genetics to chromatin organization.</p>
    </abstract>
    <abstract>
      <p>Single-cell epigenomic assays have tremendous potential to illuminate mechanisms of transcriptional control in functionally diverse cancer cell populations. However, application of these techniques to clinical tumor specimens has been hampered by the current inability to distinguish malignant from nonmalignant cells, which potently confounds data analysis and interpretation. Here, we describe Copy-scAT, an R package that uses single-cell epigenomic data to infer copy number variants (CNVs) that define cancer cells. Copy-scAT enables studies of subclonal chromatin dynamics in complex tumors like glioblastoma. By deploying Copy-scAT, we uncovered potent influences of genetics on chromatin accessibility profiles in individual subclones. Consequently, some genetic subclones were predisposed to acquire stem-like or more differentiated molecular phenotypes, reminiscent of developmental paradigms. Copy-scAT is ideal for studies of the relationships between genetics and epigenetics in malignancies with high levels of intratumoral heterogeneity and to investigate how cancer cells interface with their microenvironment.</p>
    </abstract>
    <funding-group>
      <award-group id="award741806">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100009408</institution-id>
            <institution>Fondation Brain Canada</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group id="award822838">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/501100000024</institution-id>
            <institution>Canadian Institutes of Health Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>PJT-156278</award-id>
      </award-group>
      <award-group id="award822839">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/501100000024</institution-id>
            <institution>Canadian Institutes of Health Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>PJT-173475</award-id>
      </award-group>
      <award-group id="award822840">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/501100000024</institution-id>
            <institution>Canadian Institutes of Health Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>PJT-438802</award-id>
      </award-group>
      <award-group id="award741805">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/501100000038</institution-id>
            <institution>Natural Sciences and Engineering Research Council of Canada</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group id="award741807">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/501100001804</institution-id>
            <institution>Canada Research Chairs</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Copyeditor</meta-name>
        <meta-value>Lou Notario</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec sec-type="introduction" disp-level="1">
    <title>INTRODUCTION</title>
    <p>Single-cell genomic technologies have made enormous contributions to the deconvolution of complex cellular systems, including cancer (<xref rid="R1" ref-type="bibr"><italic toggle="yes">1</italic></xref>). Single-cell RNA sequencing (scRNA-seq), particularly, has been widely used to understand the implications of intratumoral transcriptional heterogeneity for tumor growth, response to therapy, and patient prognosis (<xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>–<xref rid="R6" ref-type="bibr"><italic toggle="yes">6</italic></xref>). This field has greatly benefited from an emerging ecosystem of computational tools that have enabled complex analyses of scRNA data. Because copy number variants (CNVs) mostly accrue in malignant cells and are rare in nonmalignant tissues, computational platforms that use scRNA data to call CNVs have resulted in improved understanding of the behavior of genetic subclones in tumors (<xref rid="R7" ref-type="bibr"><italic toggle="yes">7</italic></xref>–<xref rid="R9" ref-type="bibr"><italic toggle="yes">9</italic></xref>).</p>
    <p>On the other hand, the application of single-cell epigenomic techniques, including the assay for transposase accessible chromatin (scATAC) (<xref rid="R10" ref-type="bibr"><italic toggle="yes">10</italic></xref>, <xref rid="R11" ref-type="bibr"><italic toggle="yes">11</italic></xref>), to study cancer has been slowed by computational bottlenecks. For instance, unlike scRNA-seq, now, no dedicated tool exists to call CNVs using scATAC data. This technical gap has slowed the use of scATAC to study clinical tumor specimens, which often are surgical resections that include both malignant and nonmalignant cells. Inability to deconvolute these cell populations after the generation of scATAC libraries would confound downstream analyses and interpretation of this data type.</p>
    <p>Here, we describe Copy-scAT [copy number inference using scATAC sequencing (scATAC-seq) data], a new computational tool that uses scATAC datasets to call CNVs at the single-cell level. Using scATAC datasets from adult glioblastoma (aGBM), pediatric GBM (pGBM), and multiple myeloma (MM), we demonstrate the effectiveness of Copy-scAT in calling (i) focal amplifications and (ii) chromosome arm-level gains and losses. At the most basic level, Copy-scAT can therefore discriminate between malignant and nonmalignant cells in scATAC datasets based on the presence or absence, respectively, of CNVs. This distinction is fundamental to ensure that downstream analyses include only the appropriate tumor or microenvironment cell populations. Furthermore, application of Copy-scAT allows the relationship between genetic and epigenetic differences to be investigated within individual subclones. In this regard, we show that cells that share a given CNV tend to cluster together in scATAC experiments, suggesting that genetics may impart information that results in the emergence of specific epigenetic profiles. We illustrate this principle by providing examples of coexisting genetic subclones with stem-like or more differentiated molecular profiles in GBM.</p>
  </sec>
  <sec sec-type="results" disp-level="1">
    <title>RESULTS</title>
    <sec disp-level="2">
      <title>Design and implementation of copy-scAT</title>
      <p>We designed Copy-scAT, an R package that uses scATAC-seq information to infer copy number alterations. Copy-scAT uses fragment files generated by cellranger-atac (10x Genomics) as input to generate chromatin accessibility pileups, keeping only barcodes with a minimum number of fragments (defaulting to 5000 fragments). It then generates a pileup of total coverage (number of reads × read lengths) over bins of determined length (1 Mbp as default) (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). Binned read counts then undergo linear normalization over the total signal in each cell to account for differences in read depth, and chromosomal bins that consist predominantly of zeros (at least 80% zero values) are discarded from further analysis. All parameters, including reference genome, bin size, and minimum length cutoff, are user-customizable. Copy-scAT then implements different algorithms to detect focal amplifications and larger-scale copy number variation.</p>
      <fig position="float" id="F1" fig-type="graphic" specific-use="distribute">
        <label>Fig. 1.</label>
        <caption>
          <title>Copy-scAT workflow.</title>
          <p>(<bold>A</bold>) Copy-scAT accepts barcode-fragment matrices generated by Cell Ranger (10x Genomics) as input.(<bold>B</bold>) Large peaks in normalized coverage matrices can be used to infer focal CNVs. ecDNA, extrachromosomal DNA. (<bold>C</bold>) Normalized matrices can be used to infer segmental and chromosome arm-level CNVs. (<bold>D</bold>) Example of chromosome arm-level CNV (chromosome 10p loss) called by Copy-scAT. (<bold>E</bold>) Consensus clustering is used to finalize cell assignment.</p>
        </caption>
        <graphic xlink:href="sciadv.abg6045-f1" position="float"/>
      </fig>
      <p>To call focal amplifications (<xref rid="F1" ref-type="fig">Fig. 1B</xref>), Copy-scAT generates a linear scaled profile of density over normalized 1-Mbp bins along each chromosome on a single-cell basis, centering on the median and scaling using the range. Copy-scAT then uses changepoint analysis using mean and variance (see Materials and Methods) (<xref rid="R12" ref-type="bibr"><italic toggle="yes">12</italic></xref>) to identify segments of abnormally high signal (default threshold uses <italic toggle="yes">z</italic> score &gt; 5) along each chromosome in each single cell. Optimization of settings shows that this particular threshold filters out most spurious calls, and the use of mean variance for determination of changepoint improves the detection of consensus regions because of lesser effects of low-coverage and inaccessible regions (fig. S1). These calls are then pooled together to generate consensus regions of amplification, a strategy that could enable identification of putative double minutes and extrachromosomal DNA amplifications. Each cell is then scored as positive or negative for each amplified genomic region.</p>
      <p>For larger copy number alterations, Copy-scAT pools the bins further at the chromosome arm level using a trimmed mean (keeping all bins between the 50th and 75th percentiles as default) while normalizing the data on the basis of length of CpG islands contained in each bin (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). Data are then scaled for each chromosome arm compared to a pseudodiploid control (expected signal distribution for a diploid genotype) that is modeled for each sample, and cluster assignments are generated using Gaussian decomposition. Cluster assignments are then normalized to get an estimate of copy number for each cell (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). These assignments can be optionally smoothed using alternative clustering information (Louvain clustering by default, although other clustering methods such as <italic toggle="yes">k</italic>-means may also be used) to generate consensus genotypes for each cluster of cells, improving accuracy for cells with sparse coverage (<xref rid="F1" ref-type="fig">Fig. 1E</xref>). For full details regarding the execution of Copy-scAT, see Materials and Methods. A step-by-step tutorial for Copy-scAT is available on GitHub (see Materials and Methods).</p>
    </sec>
    <sec disp-level="2">
      <title>Copy-scAT effectively calls CNVs in diverse malignancies</title>
      <p>We have tested the ability of Copy-scAT to use scATAC data to call CNVs with three different approaches and with different tumor types. First, we benchmarked Copy-scAT against CNV calls made with whole-genome sequencing (WGS) data for aGBM surgical resections (<italic toggle="yes">n</italic> = 4 samples, 4878 cells). This approach consisted in isolating nuclei from cryopreserved aGBM samples, mixing nuclei in suspension, and then using these nuclei for either scATAC or WGS library construction (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). This was meant to ensure similar representation of genetic subclones, which are usually regionally contiguous in this solid tumor, in both scATAC and WGS libraries. Confusion matrices were generated to compare chromosome arm-level gains, chromosome arm-level losses, and focal amplifications inferred by Copy-scAT, WGS, or both (<xref rid="F2" ref-type="fig">Fig. 2, B to D</xref>). Percentages were determined as number of chromosome arms with an alteration over all chrosomome arms in all samples (see Materials and Methods). Second, we benchmarked Copy-scAT against CNV calls made using pGBM surgical resections (<italic toggle="yes">n</italic> = 5 longitudinally collected samples from three different patients, 10,574 cells). In this case, scATAC and WGS libraries were generated from separate geographical regions of the same tumor (<xref rid="F2" ref-type="fig">Fig. 2, E to G</xref>). Third, we benchmarked Copy-scAT against CNV calls made with the single-cell CNV (scCNV) assay (10x Genomics) using MM clinical samples (<italic toggle="yes">n</italic> = 10 samples, 44,161 cells) (<xref rid="F2" ref-type="fig">Fig. 2, H to J</xref>, and fig. S4). Overall, we observed that Copy-scAT correctly inferred all or most of the CNVs that were called with WGS (<xref rid="F2" ref-type="fig">Fig. 2, A to G</xref>, and figs. S2 and S3) or scCNV data (<xref rid="F2" ref-type="fig">Fig. 2, H to J</xref>, and fig. S4). In total, we profiled 59,613 cells from 19 malignancies from 17 patients and were able to infer CNV status for a total of 52,123 cells (table S1). On average, we were able to call CNVs for 86.49% of cells in each sample (range, 81.77 to 93.35%) (table S1).</p>
      <fig position="float" id="F2" fig-type="image" specific-use="distribute">
        <label>Fig. 2.</label>
        <caption>
          <title>Benchmarking of Copy-scAT with three methods involving clinical samples from three distinct malignancies.</title>
          <p>(<bold>A</bold>) Banked cryopreseved aGBM samples were used for both scATAC and WGS. Nuclei were isolated from the samples, mixed, and used for both scATAC and WGS. (<bold>B</bold> to <bold>D</bold>) Percent of chromosome arm-level gains, chromosome arm-level losses, and focal amplifications detected in aGBM samples identified using both methods versus CNVs detected by scATAC or WGS alone. (<bold>E</bold>) Banked frozen pGBM samples were used for both scATAC and WGS. (<bold>F</bold> and <bold>G</bold>) Number of chromosome arm-level gains and losses detected in pGBM samples identified using both methods versus total numbers of gains detected by scATAC or WGS. (<bold>H</bold>) Fresh MM samples were used for both scATAC and 10x scCNV DNA analysis. (<bold>I</bold> and <bold>J</bold>) Number of chromosome arm-level gains and losses detected by both methods versus total numbers of gains detected by scATAC or 10x scCNV analysis. (<bold>K</bold>) Overview of raw transformed <italic toggle="yes">z</italic>-score profiles for four aGBM samples.</p>
        </caption>
        <graphic xlink:href="sciadv.abg6045-f2" position="float"/>
      </fig>
      <p>For chromosome arm-level CNV gains, precision was moderate, averaging 0.55 over all samples (range, from 0.47 in pGBM to 0.57 in myeloma), and recall was very good (average, 0.84; range, 0.77 from MM to 1.0 in aGBM) (table S2). Accuracy was approximately 0.84 (range, 0.82 to 0.87), assuming WGS as gold standard, suggesting that we were able to retrieve most of the copy number gains detected by WGS or scCNV analysis. For chromosome arm-level losses, precision was again moderate (0.53; range, 0.43 to 0.72 for different sample types), recall was 0.84 (range, 0.66 to 0.75 for different sample types), and accuracy was 0.79 (range, 0.72 to 1.0 for different sample types) (table S2). The sensitivity and specificity of focal amplifications were excellent, with perfect concordance between WGS and scATAC; however, no amplifications were detected in the profiled pGBM and MM samples, so the number of alterations detected overall was much smaller (table S2).</p>
      <p>The variation observed may reflect technical differences between the strategies used for benchmarking. The recall and accuracy were slightly lower in the MM samples, but this may, in part, be due to the relatively lower number of reads per cell for these samples, leading to greater noise, and the relative paucity of normal cells compared to brain tumors (fig. S5). As expected, the calls of Copy-scAT for aGBM were the most accurate, likely because scATAC and WGS datasets were generated by relatively homogeneous starting material, as described above. Because of its design, it is also possible that Copy-scAT is more sensitive at inferring CNVs that occur in relatively rare subclones compared to WGS, potentially explaining (in addition to true false positives) why the precision metrics are lower than recall and accuracy for our tool, as the number of CNVs inferred by Copy-scAT is often higher than the number of inferences made with WGS.</p>
      <p>Copy number calls made with Copy-scAT can be used to visualize genetic heterogeneity in clinical samples. As illustrative examples, raw heatmaps of imputed copy number for aGBM samples show evidence of interpatient and intratumoral heterogeneity (<xref rid="F2" ref-type="fig">Fig. 2K</xref>). Some of the most common CNVs inferred by Copy-scAT in these samples, particularly chromosome 7 gains and chromosome 10 losses, are hallmarks of aGBM. Overall, our results showcase the ability of Copy-scAT to use scATAC data to infer CNVs.</p>
    </sec>
    <sec disp-level="2">
      <title>scATAC data can be used to distinguish malignant from nonmalignant cells</title>
      <p>Tumor cells often harbor CNVs, and we reasoned that the use of Copy-scAT should enable the use of scATAC data to infer CNVs and therefore distinguish between malignant and nonmalignant cells. To test this hypothesis, we overlayed CNVs called by Copy-scAT onto scATAC datasets displayed in uniform manifold approximation and projection (UMAP) plots. This exercise led to the identification of cells that were clearly positive for multiple CNVs typical of GBM and others that appeared to have a normal genome (<xref rid="F3" ref-type="fig">Fig. 3, A to C</xref>). Globally, both copy number alterations and amplifications showed strong concordance within UMAP-defined clusters, even before smoothing, in keeping with a strong delineation of subclones, with minimal changes after smoothing (figs. S6 and S7). As an illustrative example, we found that the aGBM sample CGY4349 was composed of discrete cell populations with chromosome 7 gain (<xref rid="F3" ref-type="fig">Fig. 3, A and B</xref>), chromosome 10p deletion (<xref rid="F3" ref-type="fig">Fig. 3C</xref>), and along with focal amplifications at the <italic toggle="yes">MDM4</italic> (<xref rid="F3" ref-type="fig">Fig. 3D</xref>), <italic toggle="yes">PDGFRA</italic> (<xref rid="F3" ref-type="fig">Fig. 3E</xref>), and <italic toggle="yes">EGFR</italic> (<xref rid="F3" ref-type="fig">Fig. 3F</xref>) loci. Copy-scAT results suggest specific lineage relationships between subclones. For instance, chromosome 7 amplifications are clonal in this sample (<xref rid="F3" ref-type="fig">Fig. 3, A and B</xref>), whereas the chromosome 10 deletion is subclonal (<xref rid="F3" ref-type="fig">Fig. 3C</xref>). In addition, our computational tool predicts that <italic toggle="yes">PDGFRA</italic> (<xref rid="F3" ref-type="fig">Fig. 3E</xref>) and <italic toggle="yes">EGFR</italic> (<xref rid="F3" ref-type="fig">Fig. 3F</xref>) focal amplifications are mutually exclusive, a phenomenon that has been reported for aGBM (<xref rid="R13" ref-type="bibr"><italic toggle="yes">13</italic></xref>).</p>
      <fig position="float" id="F3" fig-type="graphic" specific-use="distribute">
        <label>Fig. 3.</label>
        <caption>
          <title>Detection of CNVs and identification of neoplastic clones with Copy-scAT.</title>
          <p>(<bold>A</bold>) Chromosome 7p gain in an aGBM sample (CGY4349). (<bold>B</bold>) Chromosome 7q gain in an aGBM sample. (<bold>C</bold>) Chromosome 10p loss in an aGBM sample. (<bold>D</bold>) <italic toggle="yes">MDM4</italic> amplification in an aGBM sample (CGY4349). Amplified cells, orange; nonamplified cells, gray. (<bold>E</bold>) <italic toggle="yes">PDGFRA</italic> amplification in an aGBM sample (CGY4349). Amplified cells, orange; nonamplified cells, gray. (<bold>F</bold>) <italic toggle="yes">EGFR</italic> amplification in an aGBM sample (CGY4349). Amplified cells, orange; nonamplified cells, gray. (<bold>G</bold>) ChromVAR activity score for the ASCL1 motif. (<bold>H</bold>) ChromVAR activity score for the IKZF1 motif. (<bold>I</bold>) ChromVAR activity score for the FOXG1 motif.</p>
        </caption>
        <graphic xlink:href="sciadv.abg6045-f3" position="float"/>
      </fig>
      <p>Together, these results illustrate one specific population of cells (circled in black in <xref rid="F3" ref-type="fig">Fig. 3B</xref>) that harbors several CNVs and are therefore putative cancer cells. At the same time, we also identified cells (labeled in gray in <xref rid="F3" ref-type="fig">Fig. 3B</xref>) that did not appear to have any CNVs and are therefore likely to be nonneoplastic cells from the tumor microenvironment. Equivalent results were obtained for MM (fig. S5, G to I) and pGBM samples (fig. S8). The CNV<sup>−</sup> cells often appeared in multiple scATAC clusters, suggesting the presence of multiple distinct nonneoplastic cell clusters. To validate our cell assignments with an orthogonal method, we performed differential DNA recognition motif analysis for individual cell populations identified by Copy-scAT to look for differentially accessible transcription factor (TF) motifs associated with lineage specification. Differential motif analysis with ChromVAR confirmed high scores for neural progenitor cell–associated motifs, including ASCL1 in CNV<sup>+</sup> cells (<xref rid="F3" ref-type="fig">Fig. 3G</xref>), while the putative nonneoplastic clusters showed increased occupancy at DNA recognition motifs associated with TFs associated with the hematopoietic lineages, such as IKZF1 (<xref rid="F3" ref-type="fig">Fig. 3H</xref>). Another CNV<sup>−</sup> cluster showed enrichment of FOXG1 binding motifs in accessible chromatin, in keeping with a nonneoplastic neural cell identity (<xref rid="F3" ref-type="fig">Fig. 3I</xref>). Using this approach, it was possible to discriminate between malignant and microenvironmental cells in all tumor samples analyzed (figs. S9 to S11). Clustering based on motif analysis (such as by ChromVAR) is another method for potentially distinguishing tumor from nontumor cells, and we wondered whether this would be sufficient for cell assignment. We therefore performed ChromVAR analysis followed by <italic toggle="yes">k</italic>-means clustering on our aGBM scATAC samples and compared the results to those obtained by Copy-scAT (fig. S12). While clustering based on motifs clearly delineated the more divergent hematopoietic infiltrating cells from the nontumor cells, this method was unable to distinguish between nonneoplastic brain cell types and GBM tumor cells, which have more similar accessibility profiles (fig. S12). Moreover, motif analysis is also dependent on defining a priori the motifs that would distinguish a neoplastic from a nonneoplastic cell type, which is a nontrivial task especially for GBM. Copy-scAT therefore is a useful approach to distinguish malignant from nonmalignant cells and to infer lineage relationships between genetic subclones that coexist in a tumor.</p>
    </sec>
    <sec disp-level="2">
      <title>Subclonal genetics is associated with chromatin accessibility profiles in aGBM</title>
      <p>We noticed that in most tumors that we analyzed, cells harboring a given CNV had a tendency to cluster together (<xref rid="F3" ref-type="fig">Fig. 3, A to F</xref>). Individual clusters were defined by the presence of specific CNVs (<xref rid="F4" ref-type="fig">Fig. 4, A to C</xref>). This was an unexpected observation that made us question whether clustering of scATAC data reflects the global patterns of chromatin accessibility. One possible explanation for this observation could be that chromosomal regions affected by a CNV display imbalances in the fragment depth distribution of scATAC datasets and that these patterns have a dominant effect on cluster assignment. Most scATAC-seq workflows rely on some variant of term frequency–inverse document frequency (TF-IDF) normalization rather than feature scaling, and this may amplify the effects of CNV-driven DNA content imbalances. For instance, it is possible that focal amplifications of the <italic toggle="yes">PDGFRA</italic> locus result in increased frequency of transposition events that are mapped to this site. A dominant effect of chromatin accessibility at this amplified locus could result in <italic toggle="yes">PDGFRA</italic>-amplified cells clustering together in UMAP representations of scATAC data (<xref rid="F4" ref-type="fig">Fig. 4, D and E</xref>). We found that compared to a random selection of peaks, the chromosomes that carried CNVs had significantly different numbers of peaks ranked as highly variant than chromosomes that did not have CNVs, leading to a markedly uneven distribution of top peaks (<italic toggle="yes">P</italic> &lt; 2.2 × 10<sup>–16</sup>, chi-square test; fig. S13). This was not seen in putative nonneoplastic cells, which had relatively even differentially accessible fragment distribution patterns (<italic toggle="yes">P</italic> = 0.05472, chi-square test; fig. S13). To test whether CNVs affect the clustering of scATAC data points, we removed all peaks mapping to chromosomes predicted to harbor CNVs by Copy-scAT and, lastly, reclustered all cells in each sample (<xref rid="F4" ref-type="fig">Fig. 4F</xref>). We found that although removing chromosomes with CNVs from our analyses changed the overall cluster structure of a sample (<xref rid="F4" ref-type="fig">Fig. 4G</xref>), <italic toggle="yes">PDGFRA</italic>-amplified cells still clustered close to each other (<xref rid="F4" ref-type="fig">Fig. 4H</xref>). Our results indicate that clustering after CNV removal is more granular but overall stable, with moderate cluster concordance [adjusted mutual information (AMI) 0.634] (<xref rid="F4" ref-type="fig">Fig. 4I</xref>). In this case, <italic toggle="yes">PDGFRA</italic>-amplified cells were localized to a single cluster before removing chromosomes affected by CNVs. Following removal of CNV<sup>+</sup> chromosomes and reclustering, most <italic toggle="yes">PDGFRA</italic>-amplified cells still clustered together, with only a few cells merging into a cluster that included both amplified and nonamplified cells. Comparing the most variable peaks after chromosome CNV removal showed a distribution closer to normal, supporting the marked effect of the CNVs on the identification of variant peaks (<italic toggle="yes">P</italic> = 2.418 × 10<sup>–8</sup>, fig. S13C). These data indicate that genetic subclones may have characteristic patterns of chromatin accessibility and that a cell’s genetic background may influence its likelihood of attaining specific epigenetic states.</p>
      <fig position="float" id="F4" fig-type="image" specific-use="distribute">
        <label>Fig. 4.</label>
        <caption>
          <title>Subclonal genetics influences clustering of scATAC-seq data.</title>
          <p>(<bold>A</bold> to <bold>C</bold>) CNVs in aGBM CGY4218 segregate within specific scATAC clusters. (<bold>D</bold> and <bold>E</bold>) <italic toggle="yes">PDGFRA</italic>-amplified cells cluster together in aGBM CGY4349. (<bold>F</bold>) Diagram summarizing our strategy to remove CNVs from clustering of scATAC data. All chromosomes or regions with putative CNVs were removed from downstream analyses, and cells were reclustered. (<bold>G</bold>) Reclustering of (D) following removal of chromosomes and regions affected by CNVs in CGY4349. (<bold>H</bold>) Distribution of <italic toggle="yes">PDGFRA</italic>-amplified cells following reclustering. (<bold>I</bold>) Cluster assignments of cells in CGY4349 (aGBM specimen) before and after removal of CNV-containing regions (purple, <italic toggle="yes">PDGFRA</italic>-amplified cells).</p>
        </caption>
        <graphic xlink:href="sciadv.abg6045-f4" position="float"/>
      </fig>
    </sec>
    <sec disp-level="2">
      <title>Genetic events predispose subclones to the acquisition of developmental chromatin states</title>
      <p>We further explored the notion that CNVs may shape chromatin accessibility profiles and its possible implications for cell fate determination. As an illustrative example, we focused on an aGBM sample (CGY4218) where CNVs at chromosome 1p characterized three genetic subclones, as determined with Copy-scAT: (i) a subclone with two copies of chromosome 1p, (ii) a subclone with loss of 1p, and (iii) a subclone with gain of 1p (<xref rid="F5" ref-type="fig">Fig. 5A</xref>).</p>
      <fig position="float" id="F5" fig-type="graphic" specific-use="distribute">
        <label>Fig. 5.</label>
        <caption>
          <title>Subclonal genetic alterations predispose cells to adopt developmental chromatin states.</title>
          <p>(<bold>A</bold>) Cells were clustered on the basis of scATAC ChromVAR motif scores and then shaded on the basis of the presence of one, two, or three copies of chromosome 1p. NA, not available. (<bold>B</bold>) Schematic of method used to determine putative cycling cells. (<bold>C</bold>) Cells were shaded on the basis of their predicted cycling properties. (<bold>D</bold>) Data shown in (A) projected onto pseudotime. The resulting three branches are populated preferentially by cells with gain or loss of chromosome 1p, respectively. (<bold>E</bold>) Proliferation status as shown in (B), overlaid onto pseudotime. (<bold>F</bold>) Tumor cells with chromosome 1p gain show greater proportions of proliferative cells (statistics, chi-square test). (<bold>G</bold>) Scaled chromatin accessibility at binding motifs for OLIG2 and HOXA2, two TFs associated with stemness. (<bold>H</bold>) Scaled chromatin accessibility at binding motifs for RFX2 and NFIX, two TFs associated with progenitor-like phenotypes. (<bold>I</bold>) Scaled chromatin accessibility at binding motifs for RARA::RXRA and signal transducers and activators of transcription 3 (STAT3), two TFs associated with differentiated phenotypes. (<bold>J</bold>) Enrichment plot for motif <italic toggle="yes">z</italic> scores for OLIG2 and HOXA2. (<bold>K</bold>) Enrichment plot for motif <italic toggle="yes">z</italic> scores for RFX and NFIX. (<bold>L</bold>) Enrichment plot for motif <italic toggle="yes">z</italic> scores for RARA::RXRA and STAT3. <italic toggle="yes">P</italic> values were calculated by Kruskal-Wallis test.</p>
        </caption>
        <graphic xlink:href="sciadv.abg6045-f5" position="float"/>
      </fig>
      <p>We were interested in determining whether the major genetic subclones in this tumor had similar cycling properties. Unlike scRNA-seq, we found that it is not possible to use scATAC profiles at cell cycle genes to determine whether a cell is proliferating. We reasoned that cells that are actively going through cell division have to replicate their DNA. Given that cancer cells have numerous CNVs on autosomes and could lead to noisy data, we decided to use Copy-scAT to identify cells that have doubled the number of their X chromosomes and defined them as actively cycling cells (<xref rid="F5" ref-type="fig">Fig. 5B</xref>). To validate this approach, we determined the number of cells with double the number of expected X chromosomes—i.e., putative cycling cells—in previously published scATAC datasets for mouse brain and peripheral blood mononuclear cells (PBMCs). We hypothesized that we should be able to identify cycling cells in fetal mouse brain but not in PBMCs. We detected numerous cycling cells (with twice the expected number of X chromosomes) in fetal mouse brain but not in PBMCs (fig. S14). Actively dividing cells can therefore be identified by inferring doubling of X chromosome number from baseline using scATAC data. The inferred cyling versus noncycling status was overlaid onto the UMAP plot, as shown above (<xref rid="F5" ref-type="fig">Fig. 5C</xref>). We used scATAC data to arrange cells from this tumor along pseudotime with the package STREAM (<xref rid="F5" ref-type="fig">Fig. 5D</xref>) (<xref rid="R14" ref-type="bibr"><italic toggle="yes">14</italic></xref>) and then superimposed cell cycle status determined with our X chromosome doubling method (<xref rid="F5" ref-type="fig">Fig. 5E</xref>). The results show that cells along branch 2, which is strongly enriched for cells with chromosome 1p gains, are also the most proliferative (<xref rid="F5" ref-type="fig">Fig. 5, D and E</xref>. When we quantify the number of cycling cells grouped based on their 1p status, we see an enrichment in cycling cells in the 1p gain subclone, with approximately 25% of cells actively cycling, in comparison to less than 10% of those with 1p loss and less than 2% of those with two copies of 1p (<italic toggle="yes">P</italic> = 6.509 × 10<sup>−4</sup>, chi-square test; <xref rid="F5" ref-type="fig">Fig. 5F</xref> and fig. S15). Similar results were noted when the data were analyzed by STREAM branch, with an enrichment of cycling cells in branch 2 (approximately 25% cycling cells; <italic toggle="yes">P</italic> = 7.776 × 10<sup>−14</sup>, chi-square test; fig. S15). These data therefore indicate functional differences between cells with gain or loss of chromosome 1p.</p>
      <p>We then used ChromVAR (<xref rid="R15" ref-type="bibr"><italic toggle="yes">15</italic></xref>) and STREAM-ATAC to calculate scores for TF binding motifs that are associated with neurodevelopmental processes. This analysis revealed that motifs bound by TFs that are associated with stem-like phenotypes, including OLIG2 and HOXA2, are enriched in accessible chromatin regions in cells that have one copy of chromosome 1p (<xref rid="F5" ref-type="fig">Fig. 5G</xref>). Motifs bound by TFs associated with progenitor (<xref rid="F5" ref-type="fig">Fig. 5H</xref>) and differentiated states (<xref rid="F5" ref-type="fig">Fig. 5I</xref>) were enriched in the branch with more cells showing gain of chromosome 1p. This was associated with a significant shift in the overall distribution of enrichment of these motifs in cells along the different branches of the trajectory (<xref rid="F5" ref-type="fig">Fig. 5, J to L</xref>). A distribution of genetic subclones along developmental chromatin accessibility states was observed in other tumor samples that we studied (figs. S16 to S18). Overall, the data support the notion that tumor cells may sample a discrete number of chromatin states, but their transition probabilities differ based on genotype. Consequently, chromatin states associated with each genetic subclone could manifest as different functional properties, here demonstrated at the level of cell proliferation and stemness profiles. The use of Copy-scAT therefore allows testing of hypotheses on the association between subclonal CNVs and cell behavior, which is relevant for many cancer types.</p>
      <p>To test whether the association between CNVs and chromatin profiles extended beyond chromosome 1p status, we investigated other genetic subclones. We focused on subclones that harbored <italic toggle="yes">EGFR</italic>- or <italic toggle="yes">PDGFRA</italic>-amplified cells because these focal amplifications are mutually exclusive and therefore constitute well-defined subclonal compartments, as shown above (<xref rid="F3" ref-type="fig">Fig. 3, E and F</xref>). We found that epigenetic differences within <italic toggle="yes">EGFR-</italic>amplified cells and <italic toggle="yes">PDGFRA</italic>-amplified cells in one of our aGBM samples extended beyond the amplified segments and imparted distinct global epigenetic profiles. When we examined differentially enriched TF motifs in accessible chromatin in CGY4349 cells that were amplified for <italic toggle="yes">EGFR</italic> and <italic toggle="yes">PDGFRA</italic>, we found that, as described previously (<xref rid="R5" ref-type="bibr"><italic toggle="yes">5</italic></xref>), the <italic toggle="yes">PDGFRA</italic>-amplified cells showed increased occupancy at proneural motifs such as OLIG2, ASCL1, and NEUROD1, while the <italic toggle="yes">EGFR</italic>-amplified cells exhibited enrichment for motifs of the RFX family and the AP-1 family (FOS and JUN) (table S3). Together, our results illustrate the principle that genetic subclones can have unique accessible chromatin profiles that are associated with downstream functional properties.</p>
    </sec>
  </sec>
  <sec sec-type="discussion" disp-level="1">
    <title>DISCUSSION</title>
    <p>Here, we describe Copy-scAT, a computational tool dedicated to inferring CNVs using scATAC data. Copy-scAT resolves a computational bottleneck that has restricted the application of single-cell epigenomic techniques to the study of clinical tumor samples, which are often mixtures of malignant and nonmalignant cells. The presence of nonmalignant cells can severely confound the analyses of these samples and downstream data interpretation. Cell admixture is a particular problem for scATAC data because of the inherent sparsity of these datasets and because they do not provide direct information on the expression status of cell lineage markers that could be used to solve cellular identities. For tumor types that harbor CNVs, Copy-scAT provides a simple way of solving this problem. However, a limitation of Copy-scAT is that it cannot be used with malignancies that are driven primarily by single nucleotide variants and have no or rare CNVs.</p>
    <p>It is important to note that Copy-scAT enables users to perform analyses on both malignant and nonmalignant cells from a tumor sample, because cell barcodes associated with either the presence or absence of CNVs can be selected for downstream analyses. Implementation of Copy-scAT will therefore be beneficial to groups interested in defining the epigenomes of both tumor cells and their microenvironment. Because chromatin accessibility datasets provide information on mechanisms of transcriptional regulation by distal and proximal enhancer and super enhancer elements, Copy-scAT could be useful in clarifying epigenetic mechanisms involved in tumor immune suppression and T cell exhaustion, for instance. Copy-scAT also allows scATAC studies of unsorted frozen banked cancer specimens (see Materials and Methods), because it requires no prior knowledge of cell type composition.</p>
    <p>We show that the underlying CNV architecture of tumor cells plays a significant role in clustering of scATAC data, a problem that can be amplified by the use of TF-IDF algorithms for normalization. These effects are less pronounced when clustering is based on motif activity scores (e.g., ChromVAR), likely as this incorporates data from multiple chromosomes, thus dampening the effect of variation at any one specific locus. Further studies are needed to identify the optimal way to address the effects of CNVs in downstream analyses of scATAC datasets as CNVs may represent a significant confounder and potentially mask significant biological relationships.</p>
    <p>Copy-scAT can be used to shed new light on how genetics and epigenetics interface in cancer. Our data expand on previous reports of parallel evolution of genetic and DNA methylation states in gliomas (<xref rid="R16" ref-type="bibr"><italic toggle="yes">16</italic></xref>). Here, we show that genetic subclones tend to have unique chromatin accessibility landscapes that are associated with differential DNA recognition motif usage and downstream functional properties. Consequently, some genetic subclones have greater proportions of stem-like cells, and others appear more differentiated and have diverse proliferative capacities. This is likely because specific genetic alterations (for instance, focal amplification of <italic toggle="yes">EGFR</italic> or <italic toggle="yes">PGDFRA</italic>) could result in downstream increased activity of specific TFs, which then contribute to the transcriptional output of that subclone. Our findings complement the observed high levels of intratumoral transcriptional heterogeneity in GBM (<xref rid="R5" ref-type="bibr"><italic toggle="yes">5</italic></xref>, <xref rid="R17" ref-type="bibr"><italic toggle="yes">17</italic></xref>) by suggesting that subclonal genetic alterations predispose a cell to populating particular gene regulatory states. This is in keeping with recent transcriptomics studies that have suggested that in IDH wild-type GBM, the presence of specific genetic alterations is associated with defined transcriptional states (<xref rid="R5" ref-type="bibr"><italic toggle="yes">5</italic></xref>, <xref rid="R18" ref-type="bibr"><italic toggle="yes">18</italic></xref>). Future work will be required to determine whether CNVs (i) prime cells to acquire specific chromatin accessibility states or (ii) have roles in stabilizing chromatin states of genetic subclones.</p>
    <p>Copy-scAT will enable future studies of subclonal chromatin dynamics in complex tumor types and may be an important tool to better understand the functional relationships between subclones, their microenvironment, and therapy response.</p>
  </sec>
  <sec sec-type="materials|methods" disp-level="1">
    <title>MATERIALS AND METHODS</title>
    <sec disp-level="2">
      <title>Ethics and consent statement</title>
      <p>All samples were collected and used for research with appropriate informed consent and with approval by the Health Research Ethics Board of Alberta.</p>
    </sec>
    <sec disp-level="2">
      <title>scATAC-seq sample processing</title>
      <p>GBM samples were either frozen surgical resections (pGBM) or cells dissociated from fresh surgical specimens and cryopreserved (aGBM). Samples were dissociated in a 1.5-ml microcentrfuge tube, using a wide-bore P1000 pipette followed by a narrow bore P1000 pipette in nuclear resuspension buffer [10 mM tris-HCl, 10 mM NaCl, 3 mM MgCl<sub>2</sub>, 0.1% IGEPAL, 0.1% Tween 20, 0.01% digitonin, and 1% bovine serum albumin (BSA) in phosphate-buffered saline (PBS)], then vortexed briefly, chilled on ice for 10 min, then pipetted again, and spun at 4°C at 500<italic toggle="yes">g</italic> for 5 min. This step was repeated, and the sample was then resuspended in Tween 20 wash buffer (10 mM tris-HCl, 10 mM NaCl, 3 mM MgCl<sub>2</sub>, 0.1% IGEPAL, 0.1% Tween 20, and 1% BSA in PBS) and then strained through a 35-μm cell strainer fluorescence-activated cell sorting tube (Thermo Fisher Scientific, 08-771-23) to remove debris. Nuclei were then quantified by trypan blue on the Countess II (Invitrogen), spun down at 500<italic toggle="yes">g</italic> at 4°C for 5 min, and resuspended in the nuclear isolation buffer (10x Genomics), and the rest of the scATAC was performed as per the 10x Genomics protocol. MM samples were from bone marrow aspirates collected from patients; tumor cells were isolated from mononuclear cell fractions through Ficoll gradients coupled with magnetic bead sorting of CD138<sup>+</sup> cells. scATAC libraries were prepared from GBM and MM samples using a Chromium Controller (10x Genomics). Libraries were sequenced on NextSeq 500 or Novaseq 6000 instruments (Illumina) at the Centre for Health Genomics and Informatics (CHGI; University of Calgary) using the recommended settings.</p>
    </sec>
    <sec disp-level="2">
      <title>scATAC-seq initial data analysis</title>
      <p>The raw sequencing data were demultiplexed using cellranger-atac mkfastq (Cell Ranger ATAC, version 1.1.0, 10x Genomics). scATAC-seq reads were aligned to the hg38 reference genome (GRCh38, version 1.1.0, 10x Genomics) and quantified using cellranger-atac count function with default parameters (Cell Ranger ATAC, version 1.1.0, 10x Genomics).</p>
    </sec>
    <sec disp-level="2">
      <title>scCNV analysis</title>
      <sec disp-level="3">
        <title>
Fragment pileup and normalization
</title>
        <p>The fragment file was processed, and signal was binned into bins of a preset size (default 1 Mb) across the hg38 chromosomes to generate a genome-wide read-depth map. Only barcodes with a minimum of 5000 reads were retained, to remove spurious barcodes. This flattened barcode-fragment matrix pileup was cleaned by removal of genomic intervals that were uninformative (greater than 80% zeros) and barcodes with greater than a certain number of zero intervals. Cells passing this first filter were normalized with counts per million (cpm) normalization using cpm in the edgeR package (<xref rid="R19" ref-type="bibr"><italic toggle="yes">19</italic></xref>).</p>
      </sec>
      <sec disp-level="3">
        <title>
Chromosome arm CNV analysis
</title>
        <p>The normalized barcode-fragment matrix was collapsed to the chromosome arm level, using chromosome arm information from the UCSC University of California Santa Cruz (UCSC table: cytoBand), centromeres were removed, and signal in each bin was normalized using the number of base pairs in CpG islands in the interval using the UCSC CpG islands table (UCSC table: cpgIslandExtUnmasked). The signal was then summarized using a quantile-trimmed-mean (between the 50th and 80th quantiles). Only chromosome arms with a minimum trimmed mean signal were kept for analysis.</p>
        <p>The chromosome arm signal matrix is mixed with a generated set proportion of pseudodiploid control cells, defined using the mean of chromosome segment medians with a defined SD. This cell-signal matrix is then scaled across each chromosome arm and centered on the median signal of all chromosomes. Each chromosome arm segment is then analyzed using Gaussian decomposition with Mclust (<xref rid="R20" ref-type="bibr"><italic toggle="yes">20</italic></xref>). The subsequent clusters are filtered on the basis of <italic toggle="yes">z</italic> scores and mixing proportions, and redundant clusters are combined. These <italic toggle="yes">z</italic> scores are then translated into estimated copy numbers for each segment for each barcode. The barcode CNV assignments can be optionally used to assign consensus CNVs to clusters generated in other software packages such as Loupe or Seurat/Signac.</p>
        <p>Clusters for smoothing were generated by loading the data into Signac 1.0.0 (<xref rid="R21" ref-type="bibr"><italic toggle="yes">21</italic></xref>). Datasets were quality filtered, keeping cells containing at least 3000 peak region fragments, greater than 15% of reads in peaks, and lowmapq &lt; 30,000. These were then normalized using TF-IDF, and latent semantic analysis was used for dimensionality reduction by SVD (singular value decomposition), followed by UMAP using dimensions 2:50, and nearest-neighbor clustering (using dimensions 2:50 and <italic toggle="yes">k</italic> value of 21). Smoothing was performed using Copy-scAT with a boost value of 0 (taking an average of the imputed chromosome value for the cluster followed by rounding to get a consensus value).</p>
      </sec>
      <sec disp-level="3">
        <title>
Detection of amplifications
</title>
        <p>The normalized barcode-fragment matrix was scaled, and mean-variance changepoint analysis using the changepoint package was performed for each cell and each chromosome to identify areas of abnormally high signal (<italic toggle="yes">z</italic> score greater than 5) (<xref rid="R22" ref-type="bibr"><italic toggle="yes">22</italic></xref>). The consensus coordinates of each amplification region were generated across all cells, and only abnormalities affecting a minimum number of cells were kept for analysis.</p>
      </sec>
    </sec>
    <sec disp-level="2">
      <title>scATAC trajectory analysis</title>
      <p>STREAM-ATAC and STREAM (<xref rid="R23" ref-type="bibr"><italic toggle="yes">23</italic></xref>) were used to generate pseudotime trajectories on the basis of motif occupancy profiles generated using ChromVAR (<xref rid="R24" ref-type="bibr"><italic toggle="yes">24</italic></xref>) with the JASPAR 2018 motif database (<xref rid="R25" ref-type="bibr"><italic toggle="yes">25</italic></xref>). Dimensionality reduction was performed using the top 20 components and 50 neighbors, and an initial elastic graph was generated on the two-dimensional UMAP projection using 10 clusters, using the <italic toggle="yes">K</italic>-means method with n_neighbors = 30. An elastic principal graph was constructed using the parameters epg_alpha = 0.02, epg_mu = 0.05, epg_lambda = 0.02, and epg_trimmingradius = 1.2, with branch extension using “QuantDists.” Trees were rooted using the branch with highest motif activities for OLIG2 and ETV motifs as root.</p>
    </sec>
    <sec disp-level="2">
      <title>Whole-genome sequencing</title>
      <p>DNA was extracted from residual nuclei from the same samples and tissue fragments used for scATAC-seq of aGBM samples using the Qiagen DNEasy Blood and Tissue DNA Extraction Kit (QIAGEN, no. 69504). Libraries were prepared using the NEBNext Ultra II DNA Library Prep Kit (no. E7645) and sequenced on the Novaseq 6000 (Illumina) at the CHGI (University of Calgary) in paired-end mode.</p>
    </sec>
    <sec disp-level="2">
      <title>Whole-genome data processing</title>
      <p>Genome data were aligned to the hg38 assembly using bwa mem (bwa 0.7.17) (<xref rid="R26" ref-type="bibr"><italic toggle="yes">26</italic></xref>). SAMtools was used to extract high-quality reads (<italic toggle="yes">Q</italic> &gt; 30), and Picard tools (Broad Institute) was used to remove duplicates (<xref rid="R27" ref-type="bibr"><italic toggle="yes">27</italic></xref>).</p>
    </sec>
    <sec disp-level="2">
      <title>Whole-genome SNV and CNV detection</title>
      <p>Gatk mutect2 (Broad Institute) was run on the filtered data to detect SNVs with low stringency using the following settings: --disable-read-filter MateOnSameContigOrNoMappedMateReadFilter. CNVkit was subsequently used to call CNVs using the following parameters: --filter cn -m clonal –purity 0.7 (<xref rid="R28" ref-type="bibr"><italic toggle="yes">28</italic></xref>). Adjacent segments were further combined and averaged using bedtools (<xref rid="R29" ref-type="bibr"><italic toggle="yes">29</italic></xref>).</p>
    </sec>
    <sec disp-level="2">
      <title>Data visualization and clustering</title>
      <p>Data were visualized, and UMAP plots were generated using Seurat 3.0.0 and Signac 1.0.0 (<xref rid="R21" ref-type="bibr"><italic toggle="yes">21</italic></xref>, <xref rid="R30" ref-type="bibr"><italic toggle="yes">30</italic></xref>) and Cell Loupe version 4.0.0.</p>
    </sec>
    <sec disp-level="2">
      <title>Statistical analysis</title>
      <p>Between-group differences in discrete values (e.g., chromosome peaks and branch assignments) were calculated using the chi-square test. Differences in nonparametric distributions (motif accessibility in clusters) were quantified using the Kruskal-Wallis test.</p>
    </sec>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgments</title>
    <p><bold>Funding:</bold> This work is supported by a Canada Research Chair in Brain Cancer Epigenomics (tier 2) from the Government of Canada, project grants from the Canadian Institutes of Health Research (CIHR; PJT-156278 and PJT-173475), a discovery grant from the Natural Sciences and Engineering Research Council (NSERC), and an Azrieli Future Leader in Canadian Brain Research grant to M.G.; a Clinician Investigator Program fellowship from Alberta Health Services and a fellowship from Alberta Innovates to A.N.; an Eyes High Scholarship from the University of Calgary to D.S.; a Clark Smith postdoctoral fellowship and a CIHR postdoctoral fellowship to M.J.; a Canada Research Char in Precision Oncology (tier 2) and a CIHR grant (PJT-438802) to S.M.; and an Alberta Graduate Excellence Scholarship and Alberta Innovates scholarship to A.G. This project has been made possible by the Brain Canada Foundation through the Canada Brain Research Fund, with the financial support of Health Canada and the Azrieli Foundation.</p>
    <sec>
      <p><bold>Author contributions:</bold> Conception and experimental design: A.N. and MG. Generation of datasets: A.N., K.E., J.A.C., P.N., and N.B. Data acquisition and analysis: A.N., D.S., M.J., A.G., S.M., N.B., and M.G. Data interpretation and creation of new software: A.N. and M.G. Manuscript preparation: All coauthors.</p>
    </sec>
    <sec>
      <p><bold>Competing interests:</bold> The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <p><bold>Data and materials availability:</bold> The Copy-scAT package and a tutorial are available on Github at <ext-link xlink:href="http://github.com/spcdot/CopyscAT" ext-link-type="uri">http://github.com/spcdot/CopyscAT</ext-link>. A stable release of Copy-scAT can be accessed via Zenodo (<ext-link xlink:href="https://doi.org/10.5281/zenodo.5261233" ext-link-type="uri">https://doi.org/10.5281/zenodo.5261233</ext-link>). scATAC datasets were uploaded to the Gene Expression Omnibus (GEO) repository with the following accession numbers: aGBM scATAC-seq datasets, GSE139136; scATAC-seq datasets for diagnostic pGBM samples, GSE163655; and scATAC-seq datasets for relapse pGBM samples, GSE163656. WGS data for pGBM samples were described in an earlier publication by our group (<xref rid="R31" ref-type="bibr"><italic toggle="yes">31</italic></xref>) and are available at the European Genome-Phenome Archive (EGA) with accession number EGAD00001005212. WGS datasets for aGBM are available through the EGA with accession number EGAD00001007651. All scATAC and scCNV datasets for MM are available at EGA with accession number EGAS00001005382.</p>
    </sec>
  </ack>
  <sec sec-type="supplementary-material">
    <title>Supplementary Materials</title>
    <sec>
      <title>This PDF file includes:</title>
      <supplementary-material position="float" content-type="local-data">
        <caption>
          <p>Tables S1 and S2</p>
          <p>Figs. S1 to S18</p>
        </caption>
        <media xlink:href="sciadv.abg6045_sm.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <sec>
      <title>Other Supplementary Material for this manuscript includes the following:</title>
      <supplementary-material position="float" content-type="local-data">
        <caption>
          <p>Data file S1</p>
        </caption>
        <media xlink:href="sciadv.abg6045_data_file_s1.zip">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </sec>
  <sec>
    <p>
      <ext-link xlink:href="https://en.bio-protocol.org/cjrap.aspx?eid=10.1126/sciadv.abg6045" ext-link-type="uri">View/request a protocol for this paper from <italic toggle="yes">Bio-protocol</italic>.</ext-link>
    </p>
  </sec>
  <ref-list>
    <title>REFERENCES AND NOTES</title>
    <ref id="R1">
      <label>1</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>B.</given-names><surname>Lim</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Lin</surname></string-name>, <string-name><given-names>N.</given-names><surname>Navin</surname></string-name></person-group>, 
<article-title>Advancing cancer research and medicine with single-cell genomics</article-title>. <source>Cancer Cell</source><volume>37</volume>, 
<fpage>456</fpage>–<lpage>470</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32289270</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. P.</given-names><surname>Patel</surname></string-name>, <string-name><given-names>I.</given-names><surname>Tirosh</surname></string-name>, <string-name><given-names>J. J.</given-names><surname>Trombetta</surname></string-name>, <string-name><given-names>A. K.</given-names><surname>Shalek</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Gillespie</surname></string-name>, <string-name><given-names>H.</given-names><surname>Wakimoto</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Cahill</surname></string-name>, <string-name><given-names>B. V.</given-names><surname>Nahed</surname></string-name>, <string-name><given-names>W. T.</given-names><surname>Curry</surname></string-name>, <string-name><given-names>R. L.</given-names><surname>Martuza</surname></string-name>, <string-name><given-names>D. N.</given-names><surname>Louis</surname></string-name>, <string-name><given-names>O.</given-names><surname>Rozenblatt-Rosen</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Suvà</surname></string-name>, <string-name><given-names>A.</given-names><surname>Regev</surname></string-name>, <string-name><given-names>B. E.</given-names><surname>Bernstein</surname></string-name></person-group>, 
<article-title>Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma</article-title>. <source>Science</source><volume>344</volume>, 
<fpage>1396</fpage>–<lpage>1401</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24925914</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names><surname>Darmanis</surname></string-name>, <string-name><given-names>S. A.</given-names><surname>Sloan</surname></string-name>, <string-name><given-names>D.</given-names><surname>Croote</surname></string-name>, <string-name><given-names>M.</given-names><surname>Mignardi</surname></string-name>, <string-name><given-names>S.</given-names><surname>Chernikova</surname></string-name>, <string-name><given-names>P.</given-names><surname>Samghababi</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Zhang</surname></string-name>, <string-name><given-names>N.</given-names><surname>Neff</surname></string-name>, <string-name><given-names>M.</given-names><surname>Kowarsky</surname></string-name>, <string-name><given-names>C.</given-names><surname>Caneda</surname></string-name>, <string-name><given-names>G.</given-names><surname>Li</surname></string-name>, <string-name><given-names>S. D.</given-names><surname>Chang</surname></string-name>, <string-name><given-names>I. D.</given-names><surname>Connolly</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Li</surname></string-name>, <string-name><given-names>B. A.</given-names><surname>Barres</surname></string-name>, <string-name><given-names>M. H.</given-names><surname>Gephart</surname></string-name>, <string-name><given-names>S. R.</given-names><surname>Quake</surname></string-name></person-group>, 
<article-title>Single-Cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma</article-title>. <source>Cell Rep.</source><fpage>1399</fpage>–<lpage>1410</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">29091775</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names><surname>Gojo</surname></string-name>, <string-name><given-names>B.</given-names><surname>Englinger</surname></string-name>, <string-name><given-names>L.</given-names><surname>Jiang</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Hübner</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Shaw</surname></string-name>, <string-name><given-names>O. A.</given-names><surname>Hack</surname></string-name>, <string-name><given-names>S.</given-names><surname>Madlener</surname></string-name>, <string-name><given-names>D.</given-names><surname>Kirchhofer</surname></string-name>, <string-name><given-names>I.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>J.</given-names><surname>Pyrdol</surname></string-name>, <string-name><given-names>V.</given-names><surname>Hovestadt</surname></string-name>, <string-name><given-names>E.</given-names><surname>Mazzola</surname></string-name>, <string-name><given-names>N. D.</given-names><surname>Mathewson</surname></string-name>, <string-name><given-names>M.</given-names><surname>Trissal</surname></string-name>, <string-name><given-names>D.</given-names><surname>Lötsch</surname></string-name>, <string-name><given-names>C.</given-names><surname>Dorfer</surname></string-name>, <string-name><given-names>C.</given-names><surname>Haberler</surname></string-name>, <string-name><given-names>A.</given-names><surname>Halfmann</surname></string-name>, <string-name><given-names>L.</given-names><surname>Mayr</surname></string-name>, <string-name><given-names>A.</given-names><surname>Peyrl</surname></string-name>, <string-name><given-names>R.</given-names><surname>Geyeregger</surname></string-name>, <string-name><given-names>B.</given-names><surname>Schwalm</surname></string-name>, <string-name><given-names>M.</given-names><surname>Mauermann</surname></string-name>, <string-name><given-names>K. W.</given-names><surname>Pajtler</surname></string-name>, <string-name><given-names>T.</given-names><surname>Milde</surname></string-name>, <string-name><given-names>M. E.</given-names><surname>Shore</surname></string-name>, <string-name><given-names>J. E.</given-names><surname>Geduldig</surname></string-name>, <string-name><given-names>K.</given-names><surname>Pelton</surname></string-name>, <string-name><given-names>T.</given-names><surname>Czech</surname></string-name>, <string-name><given-names>O.</given-names><surname>Ashenberg</surname></string-name>, <string-name><given-names>K. W.</given-names><surname>Wucherpfennig</surname></string-name>, <string-name><given-names>O.</given-names><surname>Rozenblatt-Rosen</surname></string-name>, <string-name><given-names>S.</given-names><surname>Alexandrescu</surname></string-name>, <string-name><given-names>K. L.</given-names><surname>Ligon</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Pfister</surname></string-name>, <string-name><given-names>A.</given-names><surname>Regev</surname></string-name>, <string-name><given-names>I.</given-names><surname>Slavc</surname></string-name>, <string-name><given-names>W.</given-names><surname>Berger</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Suvà</surname></string-name>, <string-name><given-names>M.</given-names><surname>Kool</surname></string-name>, <string-name><given-names>M. G.</given-names><surname>Filbin</surname></string-name></person-group>, 
<article-title>Single-cell RNA-seq reveals cellular hierarchies and impaired developmental trajectories in pediatric ependymoma</article-title>. <source>Cancer Cell</source><volume>38</volume>, 
<fpage>44</fpage>–<lpage>59</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32663469</pub-id></mixed-citation>
    </ref>
    <ref id="R5">
      <label>5</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>C.</given-names><surname>Neftel</surname></string-name>, <string-name><given-names>J.</given-names><surname>Laffy</surname></string-name>, <string-name><given-names>M. G.</given-names><surname>Filbin</surname></string-name>, <string-name><given-names>T.</given-names><surname>Hara</surname></string-name>, <string-name><given-names>M. E.</given-names><surname>Shore</surname></string-name>, <string-name><given-names>G. J.</given-names><surname>Rahme</surname></string-name>, <string-name><given-names>A. R.</given-names><surname>Richman</surname></string-name>, <string-name><given-names>D.</given-names><surname>Silverbush</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Shaw</surname></string-name>, <string-name><given-names>C. M.</given-names><surname>Hebert</surname></string-name>, <string-name><given-names>J.</given-names><surname>Dewitt</surname></string-name>, <string-name><given-names>S.</given-names><surname>Gritsch</surname></string-name>, <string-name><given-names>E. M.</given-names><surname>Perez</surname></string-name>, <string-name><given-names>L. N.</given-names><surname>Gonzalez Castro</surname></string-name>, <string-name><given-names>X.</given-names><surname>Lan</surname></string-name>, <string-name><given-names>N.</given-names><surname>Druck</surname></string-name>, <string-name><given-names>C.</given-names><surname>Rodman</surname></string-name>, <string-name><given-names>D.</given-names><surname>Dionne</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kaplan</surname></string-name>, <string-name><given-names>M. S.</given-names><surname>Bertalan</surname></string-name>, <string-name><given-names>J.</given-names><surname>Small</surname></string-name>, <string-name><given-names>K.</given-names><surname>Pelton</surname></string-name>, <string-name><given-names>S.</given-names><surname>Becker</surname></string-name>, <string-name><given-names>D.</given-names><surname>Bonal</surname></string-name>, <string-name><given-names>Q.-D.</given-names><surname>Nguyen</surname></string-name>, <string-name><given-names>R. L.</given-names><surname>Servis</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Fung</surname></string-name>, <string-name><given-names>R.</given-names><surname>Mylvaganam</surname></string-name>, <string-name><given-names>L.</given-names><surname>Mayr</surname></string-name>, <string-name><given-names>J.</given-names><surname>Gojo</surname></string-name>, <string-name><given-names>C.</given-names><surname>Haberler</surname></string-name>, <string-name><given-names>R.</given-names><surname>Geyeregger</surname></string-name>, <string-name><given-names>T.</given-names><surname>Czech</surname></string-name>, <string-name><given-names>I.</given-names><surname>Slavc</surname></string-name>, <string-name><given-names>B. V.</given-names><surname>Nahed</surname></string-name>, <string-name><given-names>W. T.</given-names><surname>Curry</surname></string-name>, <string-name><given-names>B. S.</given-names><surname>Carter</surname></string-name>, <string-name><given-names>H.</given-names><surname>Wakimoto</surname></string-name>, <string-name><given-names>P. K.</given-names><surname>Brastianos</surname></string-name>, <string-name><given-names>T. T.</given-names><surname>Batchelor</surname></string-name>, <string-name><given-names>A.</given-names><surname>Stemmer-Rachamimov</surname></string-name>, <string-name><given-names>M.</given-names><surname>Martinez-Lage</surname></string-name>, <string-name><given-names>M. P.</given-names><surname>Frosch</surname></string-name>, <string-name><given-names>I.</given-names><surname>Stamenkovic</surname></string-name>, <string-name><given-names>N.</given-names><surname>Riggi</surname></string-name>, <string-name><given-names>E.</given-names><surname>Rheinbay</surname></string-name>, <string-name><given-names>M.</given-names><surname>Monje</surname></string-name>, <string-name><given-names>O.</given-names><surname>Rozenblatt-Rosen</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Cahill</surname></string-name>, <string-name><given-names>A. P.</given-names><surname>Patel</surname></string-name>, <string-name><given-names>T.</given-names><surname>Hunter</surname></string-name>, <string-name><given-names>I. M.</given-names><surname>Verma</surname></string-name>, <string-name><given-names>K. L.</given-names><surname>Ligon</surname></string-name>, <string-name><given-names>D. N.</given-names><surname>Louis</surname></string-name>, <string-name><given-names>A.</given-names><surname>Regev</surname></string-name>, <string-name><given-names>B. E.</given-names><surname>Bernstein</surname></string-name>, <string-name><given-names>I.</given-names><surname>Tirosh</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Suvà</surname></string-name></person-group>, 
<article-title>An integrative model of cellular states, plasticity, and genetics for glioblastoma</article-title>. <source>Cell</source><volume>178</volume>, 
<fpage>835</fpage>–<lpage>849.e21</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31327527</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M. C.</given-names><surname>Vladoiu</surname></string-name>, <string-name><given-names>I.</given-names><surname>El-Hamamy</surname></string-name>, <string-name><given-names>L. K.</given-names><surname>Donovan</surname></string-name>, <string-name><given-names>H.</given-names><surname>Farooq</surname></string-name>, <string-name><given-names>B. L.</given-names><surname>Holgado</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Sundaravadanam</surname></string-name>, <string-name><given-names>V.</given-names><surname>Ramaswamy</surname></string-name>, <string-name><given-names>L. D.</given-names><surname>Hendrikse</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kumar</surname></string-name>, <string-name><given-names>S. C.</given-names><surname>Mack</surname></string-name>, <string-name><given-names>J. J. Y.</given-names><surname>Lee</surname></string-name>, <string-name><given-names>V.</given-names><surname>Fong</surname></string-name>, <string-name><given-names>K.</given-names><surname>Juraschka</surname></string-name>, <string-name><given-names>D.</given-names><surname>Przelicki</surname></string-name>, <string-name><given-names>A.</given-names><surname>Michealraj</surname></string-name>, <string-name><given-names>P.</given-names><surname>Skowron</surname></string-name>, <string-name><given-names>B.</given-names><surname>Luu</surname></string-name>, <string-name><given-names>H.</given-names><surname>Suzuki</surname></string-name>, <string-name><given-names>A. S.</given-names><surname>Morrissy</surname></string-name>, <string-name><given-names>F. M. G.</given-names><surname>Cavalli</surname></string-name>, <string-name><given-names>L.</given-names><surname>Garzia</surname></string-name>, <string-name><given-names>C.</given-names><surname>Daniels</surname></string-name>, <string-name><given-names>X.</given-names><surname>Wu</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Qazi</surname></string-name>, <string-name><given-names>S. K.</given-names><surname>Singh</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Chan</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Marra</surname></string-name>, <string-name><given-names>D.</given-names><surname>Malkin</surname></string-name>, <string-name><given-names>P.</given-names><surname>Dirks</surname></string-name>, <string-name><given-names>L.</given-names><surname>Heisler</surname></string-name>, <string-name><given-names>T.</given-names><surname>Pugh</surname></string-name>, <string-name><given-names>K.</given-names><surname>Ng</surname></string-name>, <string-name><given-names>F.</given-names><surname>Notta</surname></string-name>, <string-name><given-names>E. M.</given-names><surname>Thompson</surname></string-name>, <string-name><given-names>C. L.</given-names><surname>Kleinman</surname></string-name>, <string-name><given-names>A. L.</given-names><surname>Joyner</surname></string-name>, <string-name><given-names>N.</given-names><surname>Jabado</surname></string-name>, <string-name><given-names>L.</given-names><surname>Stein</surname></string-name>, <string-name><given-names>M. D.</given-names><surname>Taylor</surname></string-name></person-group>, 
<article-title>Childhood cerebellar tumours mirror conserved fetal transcriptional programs</article-title>. <source>Nature</source><volume>572</volume>, 
<fpage>67</fpage>–<lpage>73</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31043743</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>I.</given-names><surname>Tirosh</surname></string-name>, <string-name><given-names>A. S.</given-names><surname>Venteicher</surname></string-name>, <string-name><given-names>C.</given-names><surname>Hebert</surname></string-name>, <string-name><given-names>L. E.</given-names><surname>Escalante</surname></string-name>, <string-name><given-names>A. P.</given-names><surname>Patel</surname></string-name>, <string-name><given-names>K.</given-names><surname>Yizhak</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Fisher</surname></string-name>, <string-name><given-names>C.</given-names><surname>Rodman</surname></string-name>, <string-name><given-names>C.</given-names><surname>Mount</surname></string-name>, <string-name><given-names>M. G.</given-names><surname>Filbin</surname></string-name>, <string-name><given-names>C.</given-names><surname>Neftel</surname></string-name>, <string-name><given-names>N.</given-names><surname>Desai</surname></string-name>, <string-name><given-names>J.</given-names><surname>Nyman</surname></string-name>, <string-name><given-names>B.</given-names><surname>Izar</surname></string-name>, <string-name><given-names>C. C.</given-names><surname>Luo</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Francis</surname></string-name>, <string-name><given-names>A. A.</given-names><surname>Patel</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Onozato</surname></string-name>, <string-name><given-names>N.</given-names><surname>Riggi</surname></string-name>, <string-name><given-names>K. J.</given-names><surname>Livak</surname></string-name>, <string-name><given-names>D.</given-names><surname>Gennert</surname></string-name>, <string-name><given-names>R.</given-names><surname>Satija</surname></string-name>, <string-name><given-names>B. V.</given-names><surname>Nahed</surname></string-name>, <string-name><given-names>W. T.</given-names><surname>Curry</surname></string-name>, <string-name><given-names>R. L.</given-names><surname>Martuza</surname></string-name>, <string-name><given-names>R.</given-names><surname>Mylvaganam</surname></string-name>, <string-name><given-names>A. J.</given-names><surname>Iafrate</surname></string-name>, <string-name><given-names>M. P.</given-names><surname>Frosch</surname></string-name>, <string-name><given-names>T. R.</given-names><surname>Golub</surname></string-name>, <string-name><given-names>M. N.</given-names><surname>Rivera</surname></string-name>, <string-name><given-names>G.</given-names><surname>Getz</surname></string-name>, <string-name><given-names>O.</given-names><surname>Rozenblatt-Rosen</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Cahill</surname></string-name>, <string-name><given-names>M.</given-names><surname>Monje</surname></string-name>, <string-name><given-names>B. E.</given-names><surname>Bernstein</surname></string-name>, <string-name><given-names>D. N.</given-names><surname>Louis</surname></string-name>, <string-name><given-names>A.</given-names><surname>Regev</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Suvà</surname></string-name></person-group>, 
<article-title>Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma</article-title>. <source>Nature</source><volume>539</volume>, 
<fpage>309</fpage>–<lpage>313</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27806376</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. S.</given-names><surname>Venteicher</surname></string-name>, <string-name><given-names>I.</given-names><surname>Tirosh</surname></string-name>, <string-name><given-names>C.</given-names><surname>Hebert</surname></string-name>, <string-name><given-names>K.</given-names><surname>Yizhak</surname></string-name>, <string-name><given-names>C.</given-names><surname>Neftel</surname></string-name>, <string-name><given-names>M. G.</given-names><surname>Filbin</surname></string-name>, <string-name><given-names>V.</given-names><surname>Hovestadt</surname></string-name>, <string-name><given-names>L. E.</given-names><surname>Escalante</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Shaw</surname></string-name>, <string-name><given-names>C.</given-names><surname>Rodman</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Gillespie</surname></string-name>, <string-name><given-names>D.</given-names><surname>Dionne</surname></string-name>, <string-name><given-names>C. C.</given-names><surname>Luo</surname></string-name>, <string-name><given-names>H.</given-names><surname>Ravichandran</surname></string-name>, <string-name><given-names>R.</given-names><surname>Mylvaganam</surname></string-name>, <string-name><given-names>C.</given-names><surname>Mount</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Onozato</surname></string-name>, <string-name><given-names>B. V.</given-names><surname>Nahed</surname></string-name>, <string-name><given-names>H.</given-names><surname>Wakimoto</surname></string-name>, <string-name><given-names>W. T.</given-names><surname>Curry</surname></string-name>, <string-name><given-names>A. J.</given-names><surname>Iafrate</surname></string-name>, <string-name><given-names>M. N.</given-names><surname>Rivera</surname></string-name>, <string-name><given-names>M. P.</given-names><surname>Frosch</surname></string-name>, <string-name><given-names>T. R.</given-names><surname>Golub</surname></string-name>, <string-name><given-names>P. K.</given-names><surname>Brastianos</surname></string-name>, <string-name><given-names>G.</given-names><surname>Getz</surname></string-name>, <string-name><given-names>A. P.</given-names><surname>Patel</surname></string-name>, <string-name><given-names>M.</given-names><surname>Monje</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Cahill</surname></string-name>, <string-name><given-names>O.</given-names><surname>Rozenblatt-Rosen</surname></string-name>, <string-name><given-names>D. N.</given-names><surname>Louis</surname></string-name>, <string-name><given-names>B. E.</given-names><surname>Bernstein</surname></string-name>, <string-name><given-names>A.</given-names><surname>Regev</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Suvà</surname></string-name></person-group>, 
<article-title>Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq</article-title>. <source>Science</source><volume>355</volume>, 
<fpage>eaai8478</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28360267</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names><surname>Müller</surname></string-name>, <string-name><given-names>A.</given-names><surname>Cho</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>D. A.</given-names><surname>Lim</surname></string-name>, <string-name><given-names>A.</given-names><surname>Diaz</surname></string-name></person-group>, 
<article-title>CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones</article-title>. <source>Bioinformatics</source><volume>34</volume>, 
<fpage>3217</fpage>–<lpage>3219</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29897414</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J. D.</given-names><surname>Buenrostro</surname></string-name>, <string-name><given-names>P. G.</given-names><surname>Giresi</surname></string-name>, <string-name><given-names>L. C.</given-names><surname>Zaba</surname></string-name>, <string-name><given-names>H. Y.</given-names><surname>Chang</surname></string-name>, <string-name><given-names>W. J.</given-names><surname>Greenleaf</surname></string-name></person-group>, 
<article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title>. <source>Nat. Methods</source><volume>10</volume>, 
<fpage>1213</fpage>–<lpage>1218</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">24097267</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J. D.</given-names><surname>Buenrostro</surname></string-name>, <string-name><given-names>B.</given-names><surname>Wu</surname></string-name>, <string-name><given-names>U. M.</given-names><surname>Litzenburger</surname></string-name>, <string-name><given-names>D.</given-names><surname>Ruff</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Gonzales</surname></string-name>, <string-name><given-names>M. P.</given-names><surname>Snyder</surname></string-name>, <string-name><given-names>H. Y.</given-names><surname>Chang</surname></string-name>, <string-name><given-names>W. J.</given-names><surname>Greenleaf</surname></string-name></person-group>, 
<article-title>Single-cell chromatin accessibility reveals principles of regulatory variation</article-title>. <source>Nature</source><volume>523</volume>, 
<fpage>486</fpage>–<lpage>490</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26083756</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12</label>
      <mixed-citation publication-type="webpage">R. Killick, I. A. Eckley, Changepoint: An R package for changepoint analysis. <italic toggle="yes">J. Stat. Softw.</italic> (2014), doi:<ext-link xlink:href="https://10.18637/jss.v058.i03" ext-link-type="uri">10.18637/jss.v058.i03</ext-link>.</mixed-citation>
    </ref>
    <ref id="R13">
      <label>13</label>
      <mixed-citation publication-type="webpage">M. Snuderl, L. Fazlollahi, L. P. Le, M. Nitta, B. H. Zhelyazkova, C. J. Davidson, S. Akhavanfard, D. P. Cahill, K. D. Aldape, R. A. Betensky, D. N. Louis, A. J. Iafrate, Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. <italic toggle="yes">Cancer Cell</italic> (2011), doi:<ext-link xlink:href="https://10.1016/j.ccr.2011.11.005" ext-link-type="uri">10.1016/j.ccr.2011.11.005</ext-link>.</mixed-citation>
    </ref>
    <ref id="R14">
      <label>14</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>H.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>L.</given-names><surname>Albergante</surname></string-name>, <string-name><given-names>J. Y.</given-names><surname>Hsu</surname></string-name>, <string-name><given-names>C. A.</given-names><surname>Lareau</surname></string-name>, <string-name><given-names>G.</given-names><surname>Lo Bosco</surname></string-name>, <string-name><given-names>J.</given-names><surname>Guan</surname></string-name>, <string-name><given-names>S.</given-names><surname>Zhou</surname></string-name>, <string-name><given-names>A. N.</given-names><surname>Gorban</surname></string-name>, <string-name><given-names>D. E.</given-names><surname>Bauer</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Aryee</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Langenau</surname></string-name>, <string-name><given-names>A.</given-names><surname>Zinovyev</surname></string-name>, <string-name><given-names>J. D.</given-names><surname>Buenrostro</surname></string-name>, <string-name><given-names>G. C.</given-names><surname>Yuan</surname></string-name>, <string-name><given-names>L.</given-names><surname>Pinello</surname></string-name></person-group>, 
<article-title>Single-cell trajectories reconstruction, exploration and mapping of omics data with STREAM</article-title>. <source>Nat. Commun.</source><volume>10</volume>, 
<fpage>1903</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31015418</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. N.</given-names><surname>Schep</surname></string-name>, <string-name><given-names>B.</given-names><surname>Wu</surname></string-name>, <string-name><given-names>J. D.</given-names><surname>Buenrostro</surname></string-name>, <string-name><given-names>W. J.</given-names><surname>Greenleaf</surname></string-name></person-group>, 
<article-title>ChromVAR: Inferring transcription-factor-associated accessibility from single-cell epigenomic data</article-title>. <source>Nat. Methods</source><volume>14</volume>, 
<fpage>975</fpage>–<lpage>978</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28825706</pub-id></mixed-citation>
    </ref>
    <ref id="R16">
      <label>16</label>
      <mixed-citation publication-type="webpage">T. Mazor, A. Pankov, B. E. Johnson, C. Hong, E. G. Hamilton, R. J. A. Bell, I. V. Smirnov, G. F. Reis, J. J. Phillips, M. J. Barnes, A. Idbaih, A. Alentorn, J. J. Kloezeman, M. L. M. Lamfers, A. W. Bollen, B. S. Taylor, A. M. Molinaro, A. B. Olshen, S. M. Chang, J. S. Song, J. F. Costello, DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors. <italic toggle="yes">Cancer Cell</italic> (2015), doi:<ext-link xlink:href="https://10.1016/j.ccell.2015.07.012" ext-link-type="uri">10.1016/j.ccell.2015.07.012</ext-link>.</mixed-citation>
    </ref>
    <ref id="R17">
      <label>17</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. P.</given-names><surname>Patel</surname></string-name>, <string-name><given-names>I.</given-names><surname>Tirosh</surname></string-name>, <string-name><given-names>J. J.</given-names><surname>Trombetta</surname></string-name>, <string-name><given-names>A. K.</given-names><surname>Shalek</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Gillespie</surname></string-name>, <string-name><given-names>H.</given-names><surname>Wakimoto</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Cahill</surname></string-name>, <string-name><given-names>B. V.</given-names><surname>Nahed</surname></string-name>, <string-name><given-names>W. T.</given-names><surname>Curry</surname></string-name>, <string-name><given-names>R. L.</given-names><surname>Martuza</surname></string-name>, <string-name><given-names>D. N.</given-names><surname>Louis</surname></string-name>, <string-name><given-names>O.</given-names><surname>Rozenblatt-Rosen</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Suvà</surname></string-name>, <string-name><given-names>A.</given-names><surname>Regev</surname></string-name>, <string-name><given-names>B. E.</given-names><surname>Bernstein</surname></string-name></person-group>, 
<article-title>Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma</article-title>. <source>Science</source><volume>344</volume>, 
<fpage>1396</fpage>–<lpage>1401</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24925914</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18</label>
      <mixed-citation publication-type="webpage">K. C. Johnson, K. J. Anderson, E. T. Courtois, F. P. Barthel, F. S. Varn, D. Luo, M. Seignon, E. Yi, H. Kim, M. R. H. Estecio, M. Tang, N. E. Navin, R. Maurya, C. Y. Ngan, N. Verburg, P. C. de Witt Hamer, K. Bulsara, M. L. Samuels, S. Das, P. Robson, R. G. W. Verhaak, Single-cell multimodal glioma analyses reveal epigenetic regulators of cellular plasticity and environmental stress response. <italic toggle="yes">bioRxiv</italic> (2020), doi:<ext-link xlink:href="https://10.1101/2020.07.22.215335" ext-link-type="uri">10.1101/2020.07.22.215335</ext-link>.</mixed-citation>
    </ref>
    <ref id="R19">
      <label>19</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M. D.</given-names><surname>Robinson</surname></string-name>, <string-name><given-names>D. J.</given-names><surname>McCarthy</surname></string-name>, <string-name><given-names>G. K.</given-names><surname>Smyth</surname></string-name></person-group>, 
<article-title>edgeR: A bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source><volume>26</volume>, 
<fpage>139</fpage>–<lpage>140</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>L.</given-names><surname>Scrucca</surname></string-name>, <string-name><given-names>M.</given-names><surname>Fop</surname></string-name>, <string-name><given-names>T. B.</given-names><surname>Murphy</surname></string-name>, <string-name><given-names>A. E.</given-names><surname>Raftery</surname></string-name></person-group>, 
<article-title>Mclust 5: Clustering, classification and density estimation using Gaussian finite mixture models</article-title>. <source>R J.</source><volume>8</volume>, 
<fpage>289</fpage>–<lpage>317</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27818791</pub-id></mixed-citation>
    </ref>
    <ref id="R21">
      <label>21</label>
      <mixed-citation publication-type="webpage">T. Stuart, A. Srivastava, C. Lareau, R. Satija, <italic toggle="yes">bioRxiv</italic>, in press, doi:<ext-link xlink:href="https://10.1101/2020.11.09.373613" ext-link-type="uri">10.1101/2020.11.09.373613</ext-link>.</mixed-citation>
    </ref>
    <ref id="R22">
      <label>22</label>
      <mixed-citation publication-type="webpage">R. Killick, I. A. Eckley, Changepoint: An R package for changepoint analysis. <italic toggle="yes">J. Stat. Softw.</italic>
<bold>58</bold> (2014), doi:<ext-link xlink:href="https://10.18637/jss.v058.i03" ext-link-type="uri">10.18637/jss.v058.i03</ext-link>.</mixed-citation>
    </ref>
    <ref id="R23">
      <label>23</label>
      <mixed-citation publication-type="webpage">H. Chen, L. Albergante, J. Y. Hsu, C. A. Lareau, G. Lo Bosco, J. Guan, S. Zhou, A. N. Gorban, D. E. Bauer, M. J. Aryee, D. M. Langenau, A. Zinovyev, J. D. Buenrostro, G. C. Yuan, L. Pinello, Single-cell trajectories reconstruction, exploration and mapping of omics data with STREAM. <italic toggle="yes">Nat. Commun.</italic> (2019), doi:<ext-link xlink:href="https://10.1038/s41467-019-09670-4" ext-link-type="uri">10.1038/s41467-019-09670-4</ext-link>.</mixed-citation>
    </ref>
    <ref id="R24">
      <label>24</label>
      <mixed-citation publication-type="webpage">A. N. Schep, B. Wu, J. D. Buenrostro, W. J. Greenleaf, ChromVAR: Inferring transcription-factor-associated accessibility from single-cell epigenomic data. <italic toggle="yes">Nat. Methods</italic> (2017), doi:<ext-link xlink:href="https://10.1038/nmeth.4401" ext-link-type="uri">10.1038/nmeth.4401</ext-link>.</mixed-citation>
    </ref>
    <ref id="R25">
      <label>25</label>
      <mixed-citation publication-type="webpage">A. Khan, O. Fornes, A. Stigliani, M. Gheorghe, J. A. Castro-Mondragon, R. Van Der Lee, A. Bessy, J. Chèneby, S. R. Kulkarni, G. Tan, D. Baranasic, D. J. Arenillas, A. Sandelin, K. Vandepoele, B. Lenhard, B. Ballester, W. W. Wasserman, F. Parcy, A. Mathelier, JASPAR 2018: Update of the open-access database of transcription factor binding profiles and its web framework. <italic toggle="yes">Nucleic Acids Res.</italic> (2018), doi:<ext-link xlink:href="https://10.1093/nar/gkx1126" ext-link-type="uri">10.1093/nar/gkx1126</ext-link>.</mixed-citation>
    </ref>
    <ref id="R26">
      <label>26</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>H.</given-names><surname>Li</surname></string-name>, <string-name><given-names>R.</given-names><surname>Durbin</surname></string-name></person-group>, 
<article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>. <source>Bioinformatics</source><volume>25</volume>, 
<fpage>1754</fpage>–<lpage>1760</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19451168</pub-id></mixed-citation>
    </ref>
    <ref id="R27">
      <label>27</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>H.</given-names><surname>Li</surname></string-name>, <string-name><given-names>B.</given-names><surname>Handsaker</surname></string-name>, <string-name><given-names>A.</given-names><surname>Wysoker</surname></string-name>, <string-name><given-names>T.</given-names><surname>Fennell</surname></string-name>, <string-name><given-names>J.</given-names><surname>Ruan</surname></string-name>, <string-name><given-names>N.</given-names><surname>Homer</surname></string-name>, <string-name><given-names>G.</given-names><surname>Marth</surname></string-name>, <string-name><given-names>G.</given-names><surname>Abecasis</surname></string-name>, <string-name><given-names>R.</given-names><surname>Durbin</surname></string-name></person-group>, 
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source><volume>25</volume>, 
<fpage>2078</fpage>–<lpage>2079</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
    </ref>
    <ref id="R28">
      <label>28</label>
      <mixed-citation publication-type="webpage">E. Talevich, A. H. Shain, T. Botton, B. C. Bastian, CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing. <italic toggle="yes">PLoS Comput. Biol.</italic>
<bold>12</bold> (2016), doi:<ext-link xlink:href="https://10.1371/journal.pcbi.1004873" ext-link-type="uri">10.1371/journal.pcbi.1004873</ext-link>.</mixed-citation>
    </ref>
    <ref id="R29">
      <label>29</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. R.</given-names><surname>Quinlan</surname></string-name>, <string-name><given-names>I. M.</given-names><surname>Hall</surname></string-name></person-group>, 
<article-title>BEDTools: A flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics</source><volume>26</volume>, 
<fpage>841</fpage>–<lpage>842</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20110278</pub-id></mixed-citation>
    </ref>
    <ref id="R30">
      <label>30</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names><surname>Butler</surname></string-name>, <string-name><given-names>P.</given-names><surname>Hoffman</surname></string-name>, <string-name><given-names>P.</given-names><surname>Smibert</surname></string-name>, <string-name><given-names>E.</given-names><surname>Papalexi</surname></string-name>, <string-name><given-names>R.</given-names><surname>Satija</surname></string-name></person-group>, 
<article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>. <source>Nat. Biotechnol.</source><volume>36</volume>, 
<fpage>411</fpage>–<lpage>420</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29608179</pub-id></mixed-citation>
    </ref>
    <ref id="R31">
      <label>31</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M.</given-names><surname>Hoffman</surname></string-name>, <string-name><given-names>A. H.</given-names><surname>Gillmor</surname></string-name>, <string-name><given-names>D. J.</given-names><surname>Kunz</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Johnston</surname></string-name>, <string-name><given-names>A.</given-names><surname>Nikolic</surname></string-name>, <string-name><given-names>K.</given-names><surname>Narta</surname></string-name>, <string-name><given-names>M.</given-names><surname>Zarrei</surname></string-name>, <string-name><given-names>J.</given-names><surname>King</surname></string-name>, <string-name><given-names>K.</given-names><surname>Ellestad</surname></string-name>, <string-name><given-names>N. H.</given-names><surname>Dang</surname></string-name>, <string-name><given-names>F. M. G.</given-names><surname>Cavalli</surname></string-name>, <string-name><given-names>M. M.</given-names><surname>Kushida</surname></string-name>, <string-name><given-names>F. J.</given-names><surname>Coutinho</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Zhu</surname></string-name>, <string-name><given-names>B.</given-names><surname>Luu</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Ma</surname></string-name>, <string-name><given-names>A.</given-names><surname>Mungall</surname></string-name>, <string-name><given-names>R.</given-names><surname>Moore</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Marra</surname></string-name>, <string-name><given-names>M. D.</given-names><surname>Taylor</surname></string-name>, <string-name><given-names>T. J.</given-names><surname>Pugh</surname></string-name>, <string-name><given-names>P. B.</given-names><surname>Dirks</surname></string-name>, <string-name><given-names>D.</given-names><surname>Strother</surname></string-name>, <string-name><given-names>L.</given-names><surname>Lafay-Cousin</surname></string-name>, <string-name><given-names>A. C.</given-names><surname>Resnick</surname></string-name>, <string-name><given-names>S.</given-names><surname>Scherer</surname></string-name>, <string-name><given-names>D. L.</given-names><surname>Senger</surname></string-name>, <string-name><given-names>B. D.</given-names><surname>Simons</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Chan</surname></string-name>, <string-name><given-names>A. S.</given-names><surname>Morrissy</surname></string-name>, <string-name><given-names>M.</given-names><surname>Gallo</surname></string-name></person-group>, 
<article-title>Intratumoral genetic and functional heterogeneity in pediatric glioblastoma</article-title>. <source>Cancer Res.</source><volume>79</volume>, 
<fpage>2111</fpage>–<lpage>2123</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30877103</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
